Koyfin Home > Directory > Health Care > Pieris Pharma > Preferred Equity

Pieris Pharma Preferred Equity Chart (PIRS)

Pieris Pharma annual/quarterly Preferred Equity from 2014 to 2017.
  • Pieris Pharma Preferred Equity for the quarter ending September 09, 2017 was $0m a 0.00% decrease of 0m year over year
  • Pieris Pharma Preferred Equity for the last 12 months ending September 09, 2017 was $0m a 0.00% decrease of 0m year over year
Other Balance Sheet Metrics:
  • Pieris Pharma Total Assets for the quarter ending September 09, 2018 was $152m a 31.51% increase of 48m year over year
  • Pieris Pharma Other Liabilities for the quarter ending September 09, 2018 was $61m a 23.39% increase of 14m year over year
  • Pieris Pharma Total Equity for the quarter ending September 09, 2018 was $50m a 77.08% increase of 39m year over year
View Chart On Koyfin

Quarterly PIRS Preferred Equity Data

09/2017$0m
06/2017$0m
03/2017$0m
09/2016$0m
06/2016$0m
09/2014$2m

Annual PIRS Preferred Equity Data

2012$1m